Effector and memory T-cell differentiation: implications for vaccine development
The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Abstract
Recent work shows that after stimulation with antigen, CD4+ and CD8+ T cells embark on a programme of proliferation that is closely linked with the acquisition of effector functions and leads ultimately to memory-cell formation. Here, we discuss the signals required for commitment to this programme of development and the factors that might influence its progression. Models of the pathways of effector and memory T-cell differentiation are discussed, and we highlight the implications of this new understanding for the optimization of vaccine strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The relatively few naïve T-cells during early reconstitution is consistent with programmed recovery in patients following chemotherapy [39, 40], immune checkpoint blockade [20, 24], or after infection [41, 42].”
From Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm (2021) · cites this paper as [41]
In the citing paper
“These kinetics are consistent with a typical T cell response after the effector phase (53).”
From mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern (2021) · cites this paper as [53]
In the citing paper
“the central memory (CM) or effector memory (EM) differentiation states of CD4+ and CD8+ T cells have implications for durability, recirculation, tissue access, and responses upon antigen re-exposure (Kaech et al., 2002; Martin and Badovinac, 2018; Wherry et al., 2003).”
From Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination (2021) · cites this paper as Kaech et al., 2002
Citations
Cites
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Self-citationPreferential Localization of Effector Memory Cells in Nonlymphoid Tissue
Masopust, D., Vezys, V., Marzo, A. L., & Lefrançois, L. (2001) · Science · doi:10.1126/science.1058867 · Cited by 1,952
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943
Self-citationImmunological memory and protective immunity: understanding their relation
Ahmed, R., & Gray, D. (1996) · Science · doi:10.1126/science.272.5258.54 · Cited by 1,775 · cited 1×
“Stages of T-cell responses The path towards memory T-cell development continues to be delineated, but there are clearly three stages that T cells pass through as they differentiate into memory cell”
Self-citationOut of Eden: Stem Cells and Their Niches
Watt, F. M., & Hogan, A. B. L. M. (2000) · Science · doi:10.1126/science.287.5457.1427 · Cited by 1,758
Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N., Charrier, K., Sedger, L., Willis, C. R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.771 · Cited by 1,634
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo
Schluns, K. S., Kieper, W. C., Jameson, S. C., & Lefrançois, L. (2000) · Nature Immunology · doi:10.1038/80868 · Cited by 1,618
Research works printed but not linked: 1
- Tuosto, L. & Acuto, O. CD28 affects the earliest signaling events generated by TCR engagement. Eur. J. Immunol. 28, 2131–2142 (1998). · doi:10.1002/(sici)1521-4141(199807)28:07<2131::aid-immu2131>3.0.co;2-q
Cited by
Items 301–400 of 1,003
Zhang, Y., Joe, G., Zhu, J., Carroll, R., Levine, B., Hexner, E., June, C., & Emerson, S. G. (2004) · Blood · doi:10.1182/blood-2003-09-3135 · Cited by 101
Differential Kinetics and Specificity of EBV-Specific CD4+ and CD8+ T Cells During Primary Infection
Precopio, M., Sullivan, J. L., Willard, C., Somasundaran, M., & Luzuriaga, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2590 · Cited by 106
“Our data are similar to the murine LCMV data in that they demonstrate a less-robust expansion of virus-specific CD4 T cells than CD8 T cells, which is likely related to the slower rate of CD4 T cell expansion documented in in vitro and in vivo studies (21).”
ResultTelomere and adaptive immunity
Weng, N.-P. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.11.005 · Cited by 99
“Memory cells are long-lived and are capable of further rapid expansion upon re-encounter with the same antigen (Dutton et al., 1998; Kaech et al., 2002).”
Dissecting T Cell Contraction In Vivo Using a Genetically Encoded Reporter of Apoptosis
Garrod, K. R., Moreau, H. D., Garcia, Z., Lemaı̂tre, F., Bouvier, I., Albert, M. L., & Bousso, P. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.10.015 · Cited by 99
CD8+ T Cells in Leishmania Infections: Friends or Foes?
Stäger, S., & Rafati, S. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00005 · Cited by 102
“Keywords: immunology, Leishmania, CD8T cells”
BackgroundZhang, D., Cui, P., Dai, Z., Yang, B., Yao, X., Liu, Q., Hu, Z., & Zheng, X. (2019) · Nanoscale · doi:10.1039/c9nr05684j · Cited by 98
Imaging of tumour response to immunotherapy
Dromain, C., Beigelman‐Aubry, C., Pozzessere, C., Durán, R., & Digklia, A. (2020) · European Radiology Experimental · doi:10.1186/s41747-019-0134-1 · Cited by 103
Morimoto, M., Morimoto, M., Whitmire, J., Xiao, S., Anthony, R. M., Mirakami, H., Star, R. A., Urban, J. F., & Gause, W. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2424 · Cited by 98
“This model is based on responses that stimulate CD8 memory T cells (1, 21) or, more recently, CD4 Th1 memory cells (22, 23); studies of the latter population frequently rely on potentially nonphysiological approaches involving responses of Ag-specific transgenic T cells that have been transferred to Ag-immunized recip…”
BackgroundMethodPlasticity of T Cell Memory Responses to Viruses
Selin, L. K., & Welsh, R. M. (2004) · Immunity · doi:10.1016/s1074-7613(03)00356-x · Cited by 98
“…phenotype and anatomical location led vaccines that induce T cell in addition to B cell memory some investigators to describe memory T cells in terms responses may provide better protective immunity of two major subsets: central memory cells, which ex(Amara et al., 2001; Kaech et al., 2002).”
Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?
Fontana, F., Liu, D., Hirvonen, J., & Santos, H. A. (2017) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1421 · Cited by 97
Human Dendritic Cell Subsets for Vaccination
Dubsky, P. C., Ueno, H., Piqueras, B., Connolly, J., Banchereau, J., & Palucka, K. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-8216-7 · Cited by 112
“Mouse and human studies of vaccination against infectious agents (258, 259) indicate that priming should be followed by a boost 4–6 weeks later for an optimal response.”
BackgroundCytomegalovirus (CMV)-Specific cellular immune responses
Harari, A., Zimmerli, S. C., & Pantaleo, G. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.02.012 · Cited by 97
Pham, N.-L. L., Badovinac, V. P., & Harty, J. T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901203 · Cited by 97
Kang, T., Huang, Y., Zhu, Q., Cheng, H., Pei, Y., Feng, J., Xu, M., Jiang, G., Song, Q., Jiang, T., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.033 · Cited by 101
Archaeosome adjuvants: Immunological capabilities and mechanism(s) of action
Krishnan, L., & Sprott, G. D. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.02.026 · Cited by 108
Rapid default transition of CD4 T cell effectors to functional memory cells
McKinstry, K. K., Golech, S., Lee, W.-H., Huston, G., Weng, N.-P., & Swain, S. L. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070041 · Cited by 96
Disruption of SUV39H1 -Mediated H3K9 Methylation Sustains CAR T-cell Function
Jain, N., Zhao, Z., Koche, R. P., Antelope, C., Gozlan, Y., Montalbano, A., Brocks, D., Lopez, M., Dobrin, A., Shi, Y., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1319 · Cited by 95
Vaccine-Induced Effector-Memory CD8+ T Cell Responses Predict Therapeutic Efficacy against Tumors
van Duikeren, S., Fransen, M. F., Redeker, A., Wieles, B., Platenburg, G. J., Krebber, W.-J., OSSENDORP, F. A., Melief, C. J. M., & Arens, R. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201540 · Cited by 107
“The differentiation of naive CD8 T cells into effector and memory cell populations is accompanied by substantial plasticity regarding phenotype and functional capacity (3, 4), emphasizing the multifaceted and important role of this T cell subset.”
BackgroundParticle-based vaccines for transcutaneous vaccination
Combadière, B., & Mahé, B. (2007) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2007.07.015 · Cited by 95
Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
Chakraborty, S., Ye, J., Wang, H., Sun, M., Zhang, Y., Sang, X., & Zhuang, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1227833 · Cited by 113
“The immunosuppressive activity of both human and murine regulatory T-cells (Tregs) can be modulated by some of the TLRs, and it is documented in multiple reports.”
γδ T Cells Facilitate Adaptive Immunity against West Nile Virus Infection in Mice
Wang, T., Gao, Y., Scully, E., Davis, C. T., Anderson, J. F., Welte, T., Ledizet, M., Koski, R., Madri, J. A., Barrett, A., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1825 · Cited by 95
“For an acute infection such as WN encephalitis, the CD8 T cell response has three characteristic phases: a period of initial activation and expansion, a contraction or death phase, and the establishment and maintenance of memory (57).”
BackgroundEpigenetic Manipulation Restores Functions of Defective CD8+ T Cells From Chronic Viral Infection
Zhang, F., Zhou, X., DiSpirito, J. R., Wang, C., Wang, Y., & Shen, H. (2014) · Molecular Therapy · doi:10.1038/mt.2014.91 · Cited by 94
Immunopathology of RSV infection: prospects for developing vaccines without this complication
den Hurk, S. V. D. L., Mapletoft, J. W., Arsic, N., & Kovacs-Nolan, J. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.518 · Cited by 104
Positive and Negative Regulation of Cellular Immune Responses in Physiologic Conditions and Diseases
Viganó, S., Perreau, M., Pantaleo, G., & Harari, A. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/485781 · Cited by 117
“This activation results in both phenotypic and functional changes that will determine the fate of effector T cells and the efficacy of the immune response [22].”
BackgroundMemory CD4 T Cells in Influenza
Zens, K. D., & Färber, D. L. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_401 · Cited by 107
“Mechanisms underlying the transition from primary effectors to memory T cells have been an area of intense study, although this process remains incompletely understood (for reviews, see (Kaech et al. 2002; Sallusto et al. 2004; Kaech and Wherry 2007)).”
BackgroundIL-15 regulates memory CD8+ T cell O-glycan synthesis and affects trafficking
Nolz, J. C., & Harty, J. T. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72039 · Cited by 93
“Once properly activated by dendritic cells displaying antigenic peptide, costimulation, and inflammatory cytokines, naive CD8+ T cells undergo robust proliferation (1, 2).”
Wang, Y., Cella, M., Gilfillan, S., & Colonna, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903201 · Cited by 93
Nordly, P., Rose, F., Christensen, D., Nielsen, H. M., Andersen, P. L., Agger, E. M., & Foged, C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.021 · Cited by 93
“This continuous exposure to antigen is important to generate long-term immunological memory [61] and traditionally only replicating vaccines such as live attenuated vaccines or heterologous prime-boost vaccines were thus believed to confer long-lived protection [62–64].”
Insights into human CD8+ T‐cell memory using the yellow fever and smallpox vaccines
Ahmed, R., & Akondy, R. S. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2010.155 · Cited by 109
Self-citationImmunomodulation by Mesenchymal Stromal Cells and Their Clinical Applications
Rilo, H., Cagliani, J. A., Grande, D. A., Molmenti, E. P., & Miller, E. J. (2017) · Journal of Stem Cell and Regenerative Biology · doi:10.15436/2471-0598.17.022 · Cited by 102
“In several studies MSCs have been shown to have potent anti-inflammatory and immune-modulating properties over T-cell activation, proliferation, differentiation and effector function[15,16].”
BackgroundYang, T.-C., Millar, J., Groves, T., Grinshtein, N., Parsons, R., Takenaka, S., Wan, Y., & Bramson, J. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.200 · Cited by 93
“Successful manipulation of the CD8 T cell compartment for the purpose of vaccination, either in a prophylactic or therapeutic setting, will rely on an in-depth understanding of CD8 T cell activation, survival, and function (6).”
BackgroundIL-15 Regulates Both Quantitative and Qualitative Features of the Memory CD8 T Cell Pool
Sandau, M. M., Kohlmeier, J. E., Woodland, D. L., & Jameson, S. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0803355 · Cited by 91
“CD8 memory T cells produced following a single round of immunization, whereas vaccination protocols advocate repeated boosting to produce the most effective memory response (2, 7, 23, 24).”
BackgroundDeletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy
Clark, R. H., Kenyon, J. C., Bartlett, N. W., Tscharke, D. C., & Smith, G. L. (2005) · Journal of General Virology · doi:10.1099/vir.0.81417-0 · Cited by 91
“…in protection against disease induced by poxviruses (Belyakov et al., 2003; Drexler et al., 2003; Snyder et al., 2004; Tscharke et al., 2005) and other pathogens, such as Mycobacterium tuberculosis, human immunodeficiency virus (HIV) and malaria (Kaech et al., 2002; Kaufmann & McMichael, 2005).”
BackgroundCondotta, S. A., Rai, D., James, B. R., Griffith, T. S., & Badovinac, V. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202379 · Cited by 107
Northrop, J. K., Wells, A. D., & Shen, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.865 · Cited by 91
Marques, E. T. A., Chikhlikar, P. R., de Arruda, L. B., Leão, I. C., Yang, L., Wong, J., Chen, J.-S., Byrne, B. J., & August, J. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303336200 · Cited by 91
Age-associated changes within CD4+ T cells
Kovaiou, R. D., & Grubeck-Loebenstein, B. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.07.006 · Cited by 90
Miyagawa, F., Zhang, H., Terunuma, A., Ozato, K., Tagaya, Y., & Katz, S. I. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201453109 · Cited by 90
Interleukin-21-Producing HIV-1-Specific CD8 T Cells Are Preferentially Seen in Elite Controllers
Williams, L. D., Bansal, A., Sabbaj, S., Heath, S. L., Song, W., Tang, J., Zajac, A. J., & Goepfert, P. A. (2011) · Journal of Virology · doi:10.1128/jvi.01476-10 · Cited by 90
“Alterations in expression of costimulatory common gamma-chain ( c) cytokines, such as interleukin-2 (IL2), IL-7, and IL-15, are a common feature of many viral infections and have been shown to correlate with T cell nonresponsiveness (18, 33).”
BackgroundChemokine-Guided CD4+ T Cell Help Enhances Generation of IL-6RαhighIL-7Rαhigh Prememory CD8+ T Cells
Castellino, F., & Germain, R. N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.778 · Cited by 102
Zajac, P., Oertli, D., Marti, W., Adamina, M., Bolli, M., Guller, U., Noppen, C., Padovan, E., Schultz-Thater, E., Heberer, M., et al. (2003) · Human Gene Therapy · doi:10.1089/104303403322495016 · Cited by 90
“Remarkably, however, the kinetics of CTL response against viral challenges have been shown to display similar profiles (Kaech et al ., 2002 a Specific humoral responses were evaluated by an ELISA us-ing wild-type vaccinia virus as capture material and HRP-cou-pled anti-human IgG to reveal specific…”
Counting Antigen‐Specific T Cells: A New Approach for Monitoring Response to Tuberculosis Treatment?
Lalvani, A. (2004) · Clinical Infectious Diseases · doi:10.1086/381763 · Cited by 90
“The T cells enumerated by the ex vivo ELISPOT assay are effector cells that have recently encountered antigen in vivo and can rapidly release IFN-g when reexposed to antigen [6].”
BackgroundRole of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer
Sarkar, S., Hewison, M., Studzinski, G. P., Li, Y. C., & Kalia, V. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1094443 · Cited by 93
Sabbaj, S., Ghosh, M. K., Edwards, B. H., Leeth, R. R., Decker, W. D., Goepfert, P., & Aldrovandi, G. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2951 · Cited by 91
Hua, S., Lécuroux, C., Sáez‐Cirión, A., Pancino, G., Girault, I., Versmisse, P., Boufassa, F., Tauléra, O., Sinet, M., Lambotte, O., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101920 · Cited by 97
Protein Energy Malnutrition Impairs Homeostatic Proliferation of Memory CD8 T Cells
Iyer, S. S., Chatraw, J. H., Tan, W. G., Wherry, E. J., Becker, T. C., Ahmed, R., & Kapasi, Z. F. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1004027 · Cited by 88
“G eneration of long-lived immune memory is the basis of vaccination and infection-generated immunity (1).”
BackgroundSelf-citationLocation, location, location: tissue-specific regulation of immune responses
Hu, W., & Pasare, C. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0413207 · Cited by 113
“Following initial clonal expansion, T cells undergo a contraction phase, where 90% of the T cells die via apoptosis, leaving behind a long-lived memory pool that can respond to antigen rechallenge more rapidly and more robustly than the primary response [76].”
BackgroundSurviving the crash: Transitioning from effector to memory CD8+ T cell
D’Cruz, L. M., Rubinstein, M. P., & Goldrath, A. W. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.02.002 · Cited by 101
“The differentiation of effector cells to memory cells involves the progressive acquisition of these memory traits over time, generating heterogeneous phenotypic subsets [8].”
BackgroundImmunization delivered by lentiviral vectors for cancer and infectious diseases
Hu, B., Tai, A., & Wang, P. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00967.x · Cited by 89
“The prime ⁄boost strategy is also employed in vaccinations against viral infections, as it has been shown that a higher number of memory CD8 T cells could provide better protection against infections in animal models (83).”
BackgroundCD7 Is a Differentiation Marker That Identifies Multiple CD8 T Cell Effector Subsets
Aandahl, E. M., Sandberg, J. K., Beckerman, K., Taskén, K., Moretto, W. J., & Nixon, D. F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2349 · Cited by 87
Smyk‐Pearson, S., Tester, I. A., Klarquist, J. S., Palmer, B. E., Pawlotsky, J., Golden‐Mason, L., & Rosen, H. R. (2007) · Journal of Virology · doi:10.1128/jvi.01581-07 · Cited by 87
“As recently described by our group (8), CD127 (IL-7R ) serves as a “signature” for cellular fitness, demarcating effector cells that survive long term and retain functional responsiveness (15).”
BackgroundSong, K., Rabin, R. L., Hill, B. J., De Rosa, S. C., Perfetto, S. P., Zhang, H. H., Foley, J. F., Reiner, J. S., Liu, J., Mattapallil, J. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409720102 · Cited by 87
Fann, M., Godlove, J. M., Catalfamo, M., Wood, W. H., Chrest, F. J., Chun, N., Granger, L., Wersto, R., Madara, K., Becker, K., et al. (2006) · Blood · doi:10.1182/blood-2006-02-005520 · Cited by 86
“†Based on the expression changes after activation, genes are divided into 2 groups: (1) differences are maintained at 16 and 72 hours designated as M-1 or N-1, and (2) differences are decreased at 16 and 72 hours designated as M-2 and N-2, where M indicates memory cell and N indicates naive cell.”
BackgroundThe nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation
Goncalves, L., Albarrán, B., Salmen, S., Borges, L., Fields, H. A., Montes, H., Sóyano, A., Díaz, Y., & Berrueta, L. (2004) · Virology · doi:10.1016/j.virol.2004.04.042 · Cited by 86
Schmidt, J. D., Ahlström, M. G., Johansen, J. D., Dyring‐Andersen, B., Agerbeck, C., Nielsen, M. M., Poulsen, S. S., Woetmann, A., Ødum, N., Thomsen, A. R., et al. (2016) · Contact Dermatitis · doi:10.1111/cod.12715 · Cited by 96
Enhanced Sensitization and Elicitation Responses Caused by Mixtures of Common Fragrance Allergens
Bonefeld, C. M., Nielsen, M. M., Rubin, I. M. C., Vennegaard, M. T., Dabelsteen, S., Gimenéz-Arnau, E., Lepoittevin, J.-P., Geisler, C., & Johansen, J. D. (2011) · Contact Dermatitis · doi:10.1111/j.1600-0536.2011.01945.x · Cited by 85
Capone, S., Zampaglione, I., Vitelli, A., Pezzanera, M., Kierstead, L. S., Burns, J., Ruggeri, L., Arcuri, M., Cappelletti, M., Meola, A., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7462 · Cited by 92
“Ag-specific T lymphocytes with a balance between CD4 and CD8 T cell responses (37).”
BackgroundThe Tec kinases Itk and Rlk regulate conventional versus innate T‐cell development
Prince, A., Yin, C., Enos, M., Felices, M., & Berg, L. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00746.x · Cited by 88
“After antigen encounter, CD8 T cells also gain functions to become cytotoxic effector cells, including the expression of perforin and granzyme and the capacity for interferon-c (IFNc) production and release (29).”
BackgroundCD8 T-Cell Memory Differentiation during Acute and Chronic Viral Infections
Kalia, V., Sarkar, S., & Ahmed, R. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6451-9_7 · Cited by 96
Self-citationChemokines: Control of Primary and Memory T-Cell Traffic
Schaerli, P., & Moser, B. (2004) · Immunologic Research · doi:10.1385/ir:31:1:57 · Cited by 87
Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection
Ndhlovu, Z. M., Kazer, S. W., Nkosi, T., Ogunshola, F. J., Muema, D., Anmole, G., Swann, S. A., Moodley, A., Dong, K. L., Reddy, T., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau0528 · Cited by 92
“The functional attributes of antigen-specific T cell responses are influenced by the differentiation state of the cell (37).”
TNF family ligands define niches for T cell memory
Sabbagh, L., Snell, L. M., & Watts, T. H. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.06.001 · Cited by 83
TCR signaling requirements for activating T cells and for generating memory
Zehn, D., King, C. G., Bevan, M. J., & Palmer, E. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0965-x · Cited by 97
Jo, N., Hidaka, Y., Kikuchi, O., Fukahori, M., Sawada, T., Aoki, M., Yamamoto, M., Nagao, M., Morita, S., Nakajima, T. E., et al. (2023) · Nature Aging · doi:10.1038/s43587-022-00343-4 · Cited by 94
Advanced technologies for the development of infectious disease vaccines
Gupta, A., Rudra, A., Reed, K., Langer, R., & Anderson, D. G. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01041-z · Cited by 97
“Effector memory T cells, by contrast, circulate between lymphoid organs and tissues and are slower to infiltrate infected tissue and mount an immune response 304 .”
Architects of immunity: How dendritic cells shape CD8 + T cell fate in cancer
Bhandarkar, V., Dinter, T., & Spranger, S. (2025) · Science Immunology · doi:10.1126/sciimmunol.adf4726 · Cited by 96
B Cells Help Alloreactive T Cells Differentiate Into Memory T Cells
Ng, Y. ‐., Oberbarnscheidt, M. H., Chandramoorthy, H. C. K., Hoffman, R., & Chalasani, G. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03223.x · Cited by 81
“Early costimulatory interactions via CD28/B7 and CD40/CD40L and IL-2 regulate clonal expansion of CD4 and CD8 T cells following antigen exposure (65).”
BackgroundMantoux Test as a model for a secondary immune response in humans
Vukmanovic‐Stejic, M., Reed, J. R., Lacy, K. E., Rustin, M. H. A., & Akbar, A. N. (2006) · Immunology Letters · doi:10.1016/j.imlet.2006.08.002 · Cited by 92
Ladell, K., Hellerstein, M. K., Cesar, D., Busch, R., Boban, D., & McCune, J. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.7907 · Cited by 81
“In mice, long-lived memory CD8 T cells are thought to originate from effector CD8 T cells that survive a death phase that follows the initial phase of T cell activation and expansion (13).”
BackgroundInduction of Human T Cell–Mediated Immune Responses after Primary and Secondary Smallpox Vaccination
Kennedy, J. S., Frey, S. E., Yan, L. K., Rothman, A. L., Cruz, J., Newman, F. K., Orphin, L., Belshe, R. B., & Ennis, F. A. (2004) · The Journal of Infectious Diseases · doi:10.1086/423848 · Cited by 84
Immunogenicity of human embryonic stem cells
Grinnemo, K., Sylvén, C., Hovatta, O., Dellgren, G., & Corbascio, M. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0486-3 · Cited by 87
“The mechanism of memory T cell generation and survival is a major field of investigation and tolerance induction in these cells could well be the major obstacle to clinical tolerance induction (Kaech et al. 2002).”
BackgroundEnumeration and Characterization of Human Memory T Cells by Enzyme-Linked Immunospot Assays
Calarota, S. A., & Baldanti, F. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/637649 · Cited by 80
“This paper describes the principle of ELISPOT assays and discusses their application in the evaluation of immune correlates of clinical interest with a focus on the vaccine field.”
Kidney Failure Associates With T Cell Exhaustion and Imbalanced Follicular Helper T Cells
Hartzell, S., Bin, S., Cantarelli, C., Haverly, M., Manrique, J., Angeletti, A., Manna, G. L., Murphy, B. T., Zhang, W., Levitsky, J., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583702 · Cited by 86
Wang, H., Gao, Z., Jiao, D., Zhang, Y., Zhang, J., Wang, T., Huang, Y., Zheng, D., Hou, J., Ding, D., et al. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202214499 · Cited by 88
Host Responses from Innate to Adaptive Immunity after Vaccination: Molecular and Cellular Events
Kang, S., & Compans, R. W. (2009) · Molecules and Cells · doi:10.1007/s10059-009-0015-1 · Cited by 86
“A hallmark of the vertebrate adaptive immune system is its ability to remember an encounter with a foreign antigen even for a whole lifetime in cases of some vaccine or pathogen antigens (Kaech et al., 2002).”
Walker, E., Haley, D. P., Miller, W. L., Floyd, K., Wisner, K. P., Sanjuan, N., Maecker, H. T., Romero, P. J., Hu, H., Alvord, W. G., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0095-03 · Cited by 79
“We also demonstrated that these circulating long-term tetramer CD8 T cells had elevated proliferation responses after IVS, a trait characteristic of memory T cells (26).”
BackgroundVirus‐specific CD8 T cells: activation, differentiation and memory formation
Wiesel, M., Walton, S. M., Richter, K., & Oxenius, A. (2009) · Apmis · doi:10.1111/j.1600-0463.2009.02459.x · Cited by 93
The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans
Islam, S. A., Thomas, S. Y., Hess, C., Medoff, B. D., Means, T. K., Brander, C., Lilly, C. M., Tager, A. M., & Luster, A. D. (2005) · Blood · doi:10.1182/blood-2005-06-2362 · Cited by 84
Roads to the development of improved pertussis vaccines paved by immunology
Brummelman, J., Wilk, M. M., Han, W. G. H., van Els, C. A. C. M., & Mills, K. H. G. (2015) · Pathogens and Disease · doi:10.1093/femspd/ftv067 · Cited by 90
HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients
Tippalagama, R., Singhania, A., Dubelko, P., Arlehamn, C. S. L., Crinklaw, A., Pomaznoy, M., Seumois, G., Silva, A. D. D., Premawansa, S., Vidanagama, D. S., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100011 · Cited by 88
“Effector T cells originate from division of antigen-specific T cells upon TCR activation (1).”
BackgroundChemokine regulation of naı̈ve T cell traffic in health and disease
Weninger, W., & von Andrian, U. H. (2003) · Seminars in Immunology · doi:10.1016/j.smim.2003.08.007 · Cited by 77
“This expansion is followed by a retraction phase during which the majority of effector cells undergo apoptosis, leaving behind a stable population of antigen-specific memory cells (reviewed in [4,5]).”
BackgroundT cells and their partners: the chemokine dating agency
Viola, A., Contento, R. L., & Molon, B. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.07.004 · Cited by 76
Effects of IL-7 on memory CD8+ T cell homeostasis are influenced by the timing of therapy in mice
Nanjappa, S. G., Walent, J. H., Morre, M., & Suresh, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32020 · Cited by 96
Immunogenomics and systems biology of vaccines
Buonaguro, L., & Pulendran, B. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00971.x · Cited by 79
Barrios, K., & Celis, E. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1259-8 · Cited by 75
T-cell priming in bone marrow: the potential for long-lasting protective anti-tumor immunity
Schirrmacher, V., Feuerer, M., Fournier, P., Ahlert, T., Umansky, V., & Beckhove, P. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.10.001 · Cited by 76
Kovaiou, R. D., Weiskirchner, I., Keller, M., Pfister, G., Cioca, D. P., & Grubeck-Loebenstein, B. (2005) · International Immunology · doi:10.1093/intimm/dxh314 · Cited by 76
Böttcher, J. P., Schanz, O., Wohlleber, D., Abdullah, Z., Debey-Pascher, S., Staratschek-Jox, A., Höchst, B., Hegenbarth, S., Grell, J., Limmer, A., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.02.008 · Cited by 76
Maintenance of long‐term tumour‐specific T‐cell memory by residual dormant tumour cells
Mahnke, Y. D., Schwendemann, J., Beckhove, P., & Schirrmacher, V. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02163.x · Cited by 76
In remembrance of things past: memory T cells and transplant rejection
Valujskikh, A., & Lakkis, F. G. (2003) · Immunological Reviews · doi:10.1046/j.1600-065x.2003.00087.x · Cited by 76
“latory requirements than naı̈ve T cells (1, 2, 55), they are likely to be resistant to the effects of costimulatory blockade and subsequently to tolerance induction.”
BackgroundMultifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway
Cheng, L., Zhang, P., Liu, Y., Liu, Z., Tang, J., Xu, L., & Liu, J. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122259 · Cited by 81
Byun, E., Kim, W. S., Kim, J., Jung, I. D., Park, Y., Kim, H., Cho, S., & Shin, S. J. (2012) · The FASEB Journal · doi:10.1096/fj.11-199588 · Cited by 75
“tuberculosis infection, CD4 and CD8 T cells expand into effector cells and then differentiate into long-lived memory cells (46).”
BackgroundRoles of IFN-γ and γδ T Cells in Protective Immunity Against Blood-Stage Malaria
Inoue, S.-I., Niikura, M., Mineo, S., & Kobayashi, F. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00258 · Cited by 75
Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis
Serra-Vidal, M. M., Latorre, I., Franken, K. L. M. C., Díaz, J., de Souza-Galvão, M. L., Casas, I., Maldonado, J., Milà, C., Solsona, J., Jiménez-Fuentes, M. Á., et al. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00517 · Cited by 78
“It is thought that central memory T cells, but not effector ones, may take several days (rather than hours) to produce effector cytokines (Kaech et al., 2002; Dheda et al., 2007).”
BackgroundMiao, T., Symonds, A. L. J., Singh, R. K., Symonds, J. D., Ogbe, A., Omodho, B., Zhu, B., Li, S., & Wang, P. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20160553 · Cited by 81
“6 B, and Dataset S1), including lineage-specific transcription factors (Tbx21, Runx2, Runx3, Rora, Rorc, Bhlhe40, Zeb2, and Prdm1; Kaech and Cui, 2012); genes required for effector function (Ifng, Gzma, Gzmb, Gzmk, Csf1, Il17a, Il1b, and Il18; Kaech et al., 2002; Williams and Bevan, 2007) and migration of effector T c…”
BackgroundInfluentialIFN-γ Receptor Signaling Regulates Memory CD8+ T Cell Differentiation
Sercan-Alp, Ö., Stoycheva, D., Hämmerling, G. J., Arnold, B., & Schüler, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902708 · Cited by 73
“In the following contraction phase, most effector CD8 T cells die; few cells survive to form a long-livedmemory pool (1, 2).”
BackgroundButler, N. S., Nolz, J. C., & Harty, J. T. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01594.x · Cited by 74
Francavilla, V., Accapezzato, D., Salvo, M. D., Rawson, P. M., Cosimi, O., Lipp, M., Cerino, A., Cividini, A., Mondelli, M. U., & Barnaba, V. (2004) · European Journal of Immunology · doi:10.1002/eji.200324539 · Cited by 75
Immunity to Visceral Leishmaniasis Using Genetically Defined Live-Attenuated Parasites
Selvapandiyan, A., Dey, R., Gannavaram, S., Lakhal-Naouar, I., DUNCAN, R. C., Salotra, P., & Nakhasi, H. L. (2011) · Journal of Tropical Medicine · doi:10.1155/2012/631460 · Cited by 80
Zhou, F., Gao, J., Xu, Z., Li, T., Gao, A., Sun, F. Z., Wang, F., Wang, W., Geng, Y., Zhang, F., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101025 · Cited by 71
Metadata
- Authors
- Kaech, S. M., Wherry, E. J., & Ahmed, R.
- Affiliations
- Emory University (US)
- Corresponding author
- Ahmed, Rafi
- Venue
- Nature Reviews Immunology
- Published
- 2002-04-01
- Volume
- 2
- Issue
- 4
- Pages
- 251-262
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2170904230
- Cited by
- 1,865
- References
- 137
- Citations by year
- 2026: 54 · 2025: 91 · 2024: 94 · 2023: 96 · 2022: 101 · 2021: 73 · 2020: 50 · 2019: 48 · 2018: 45 · 2017: 61 · 2016: 62 · 2015: 62 · 2014: 81 · 2013: 65 · 2012: 64
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- effector T cells, memory T cells, T cell differentiation, CD4+ T cells, CD8+ T cells, T cell proliferation, antigen stimulation, vaccine design
- MeSH terms
- Animals, Cell Differentiation, Humans, Immunologic Memory, T-Lymphocytes, Vaccines, CD4-Positive T-Lymphocytes, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.